Theseus Pharmaceuticals

Theseus Pharmaceuticals

    Company info:

  • 1-50
  • 2017
  • Cambridge, MA
  • 100-500M

Claim company profile

About company:

Theseus Pharmaceuticals is designing kinase inhibitors for targeted cancer treatments. Cancer resistance occurs when cancerous cells mutate to circumvent the effect of a therapeutic. Resistance is commonly seen in therapies that target protein kinases. Theseus is outsmarting cancer resistance by developing next-generation tyrosine kinase inhibitors that offer more effective ways to treat cancer. Theseus’ approach involves using their unique drug discovery platform to develop pan-variant tyrosine kinase inhibitor therapies that uses chemical structure analyses with biomarker-guided design. Theseus’ lead candidate inhibitor, THE-630, has the potential to generate a robust and durable response in patients with gastrointestinal stromal tumors.


Theseus Pharmaceuticals
Associate Director, DMPK
Cambridge, MA|9 days ago
Theseus Pharmaceuticals
Director of Analytical Development/Quality Control...
Cambridge, MA|33 days ago
Theseus Pharmaceuticals
Executive Assistant
Cambridge, MA|51 days ago
Theseus Pharmaceuticals
Director, Discovery Biology
Cambridge, MA|100+ days ago
Theseus Pharmaceuticals
VP, Computational Chemistry/Cheminformatics
Cambridge, MA|100+ days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy